Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis

• US 10,072,293 B2
• Filed: 04/02/2012
• Issued: 09/11/2018
• Est. Priority Date: 03/31/2011
• Status: Active Grant

• Current Assignee: The Procter & Gamble Company
• Original Assignee: The Procter & Gamble Company
• Inventors: Mills, Kevin John, Binder, Robert Lloyd, Youngquist, Robert Scott, Xu, Jun, Hu, Ping, Tamura, Makio
• Primary Examiner(s): Lin, Jerry
• Application Number:
  US13/437,072
• Publication Number:
  US 20120258074A1
• Time in Patent Office: 2,353 Days
• Field of Search: 702 19
• CPC Class Codes: A61P 17/00 Drugs for dermatological disorders
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2600/136 Screening for pharmacological compounds
• CPC Class Codes: C12Q 2600/148 Screening for cosmetic compounds
• CPC Class Codes: C12Q 2600/158 Expression markers

Abstract

Methods and systems for determining functional relationships between a skin-active agent and a skin condition of interest, and methods and systems for identifying cosmetic agents effective for treatment of dandruff, as well as the use of agents identified by such methods and systems for the preparation of cosmetic compositions, personal care products, or both are provided. Methods for developing in vitro models of skin disease and models for specific skin diseases are also provided.

Claims

1. A method for constructing a data architecture for use in identifying connections between perturbagens and genes associated with dandruff, and preparing a dandruff care composition comprising:

(a) providing a gene expression profile for a control human epidermal keratinocyte cell;

(b) generating a gene expression profile for a human epidermal keratinocyte cell exposed to at least one perturbagen, by extracting a biological sample from the treated cell and subjecting the biological sample to microarray analysis via a microarray scanner wherein generating the gene expression profile in at least one of (a) and (b) comprises

i. isolating RNA from the human epidermal keratinocyte cell, and

ii. creating cDNA from the isolated RNA;

(c) identifying genes differentially expressed in response to the at least one perturbagen by comparing the gene expression profiles of (a) and (b);

(d) creating an ordered list comprising identifiers representing the differentially expressed genes, wherein the identifiers are ordered according to the differential expression of the genes;

(e) storing the ordered list as a keratinocyte instance on at least one computer readable medium; and

(f) constructing a data architecture of stored keratinocyte instances by repeating (a) through (e), wherein the at least one perturbagen of step (a) is different qualitatively or quantitatively for each keratinocyte instance

(g) querying the data architectures of stored keratinocyte instances with at least one dandruff gene expression signature, wherein querying comprises comparing the at least one dandruff gene expression signature to each stored keratinocyte instance, wherein the dandruff gene expression represents genes differentially expressed in association with dandruff;

(h) assigning a connectivity score to each of the instances; and

(i) preparing a dandruff care composition comparing at least one perturbagen, wherein the connectivity score of the instance associated with the at least one perturbagen has a negative correlation.

2. A method according to claim 1, comprising using a programmable computer to perform one or more of steps (c), (d), (e) and (f).

3. A method according to claim 1, wherein the ordered list comprises the ordered list of identifiers in association with a numerical ranking for the identifier corresponding to its rank in the ordered list.

4. A method according to claim 1, wherein the biological sample comprises mRNA.

5. A method according to claim 1, wherein the microarray is a global microarray or a specific microarray, wherein the specific microarray comprises oligonucleotides which hybridize to genes corresponding to a gene expression signature for a cellular phenotype.

6. A method according to claim 1, wherein the step of constructing the data architecture of stored keratinocyte instances by repeating steps (a) through (e) comprises repeating steps (a) through (e) for between about 50 and about 50,000 instances.

7. A method according to claim 6, wherein the step of constructing the data architecture of stored keratinocyte instances comprises repeating steps (a) through (e) for between about 1000 and about 20,000 instances.

8. A method according to claim 1, wherein the at least one perturbagen is an anti-dandruff agent.

9. A method according to claim 8, wherein the anti-dandruff agent induces a host response to produce a host effect, or induces anti-fungal activity to produce an anti-fungal effect, or both.

10. The method according to claim 9, wherein the anti-dandruff agent induces a host response to produce a host effect.

11. The method according to claim 10, wherein the host response is restoration of epidermal homeostasis present in healthy scalp skin.

12. The method according to claim 11, wherein restoration of epidermal homeostasis is assessed by measuring a shift in a transcriptional profile derived from scalp skin of the host toward a transcriptional profile of healthy scalp skin.

13. A method according to claim 1, wherein the identifiers are selected from the group consisting of gene names, gene symbols, microarray probe set ID values, and combinations thereof.

14. A method according to claim 1, wherein the ordered list is arranged so that an identifier associated with a most up-regulated gene is positioned at the top of the ordered list and an identifier associated with a most down-regulated gene is positioned at the bottom of the ordered list.

15. A method according to claim 14, wherein the ordered list of each keratinocyte instance is arranged so that an identifier associated with each gene that is not differentially expressed is positioned between the identifier associated with the most up-regulated gene and the identifier associated with the most down-regulated gene.

16. A method according to claim 1, wherein each keratinocyte instance comprises between about 1,000 and about 50,000 identifiers.

17. A method according to claim 1, wherein each keratinocyte instance comprises metadata for the at least one perturbagen associated with the instance.

18. A method according to claim 1, wherein at least one perturbagen is an anti-fungal agent.

19. A method according to claim 18, wherein an anti-fungal agent comprises zinc pyrithione (ZPT), selenium sulfide or both.

20. A method according to claim 1, wherein at least one perturbagen comprises an environmental stimuli.

21. The method according to claim 10 wherein the host response comprises one or more of inducing lipid metabolism, suppressing inflammation, suppressing cell proliferation, suppressing cell apoptosis and normalizing cell differentiation.

22. The method according to claim 21, wherein the host response comprises inducing lipid metabolism and suppressing inflammation.